Nurix CSO Gwenn Hansen sells 4,111 shares for $100,068.32
Reuters2026/08/05 10:40- Nurix Therapeutics Chief Scientific Officer Gwenn Hansen sold 4,111 common shares on Aug. 4.
- Sales priced at USD 23.87 and USD 24.64 per share.
- Post-transaction direct holdings totaled 117,227 common shares.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The 10-year U.S. Treasury yield climbs to 4.8%, erasing the dividend advantage of utility stocks; the sector’s rebound depends on interest rate stabilization rather than technical signals.
As U.S. Treasury yields continue to climb, the American utilities sector is experiencing a significant pullback—a rise in yields not only erodes the relative appeal of the sector’s dividends but also raises financing costs for the most capital-intensive industries within this market.
Euro holds gains above 1.1600 despite robust US jobs data, traders eye ECB rate decision
Port of Tauranga wins fast-track approval for Stella Passage development
Crypto prices
More
